🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Status
Recruiting
Location
Chinese PLA General hospital
Start Date
2021-01-01
Trial ID
NCT06333561
This is a Phase 1, open-label, dose escalation study in patients with advan...
Status
Completed
Location
Next Oncology
Start Date
2020-09-23
Trial ID
NCT04501276
Treatments Being Tested
Research purposes: the research design in the late more than 2 lines TNBC p...
Status
Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2024-12-06
Trial ID
NCT06878625
This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-04-30
Trial ID
NCT06370754
The investigators propose to initiate a study assessing the efficacy and sa...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-02-01
Trial ID
NCT06241105
Treatments Being Tested
Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Status
Recruiting
Location
the First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-01
Trial ID
NCT06896422
Treatments Being Tested
Objectives: To evaluate the non-inferiority of disitamab vedotin plus gemci...
Status
Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2026-07-01
Trial ID
NCT07693959
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
This study is a prospective, multicenter, multi-cohort Phase III clinical t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-20
Trial ID
NCT07332221
Treatments Being Tested